Company Filing History:
Years Active: 2017-2022
Title: The Innovative Contributions of Bertrand Alluis in Rapid-Acting Insulin Formulations
Introduction
Bertrand Alluis is a notable inventor based in Genas, France, with a portfolio of five patents to his name. He has made significant strides in the field of pharmaceutical formulations, particularly in the development of rapid-acting insulin formulations. His work has contributed to the advancement of diabetes treatment, showcasing his dedication to improving patient care through innovative solutions.
Latest Patents
One of Alluis’s latest patents details a rapid-acting insulin formulation that comprises a substituted anionic compound. This composition is designed as an aqueous solution that includes insulin and at least one such compound. The substituted anionic compound has a backbone formed from a discrete number of saccharide units, ranging between 1 and 8. These units can be identical or different and are linked through various glycoside bonds. The saccharide units primarily consist of hexoses, which can be in either cyclic form or open reduced form. Notably, this compound includes partially substituted carboxyl functional groups, where the unsubstituted carboxyl functional groups are salifiable. This groundbreaking formulation also incorporates pharmaceutical applications, further demonstrating its potential impact on diabetes management.
Career Highlights
Bertrand Alluis is associated with Adocia, a company focused on developing innovative therapeutic solutions. His contributions have significantly enhanced the company’s reputation within the pharmaceutical industry. With each patent, he has underscored his commitment to research and development, and his work reflects the advancement of modern medicine.
Collaborations
Throughout his career, Alluis has collaborated with esteemed colleagues such as Gérard Soula and Olivier Soula. Working alongside these talented individuals has allowed him to push the boundaries of innovation in pharmaceutical sciences. Their joint efforts have resulted in meaningful contributions to the field, fostering advancements that benefit patients globally.
Conclusion
In conclusion, Bertrand Alluis stands out as a significant figure in the realm of pharmaceutical innovations, specifically in developing rapid-acting insulin formulations. His five patents highlight his valuable contributions to the medical field, showcasing a remarkable blend of creativity and scientific research. As pharmaceutical technology continues to evolve, the work of inventors like Alluis paves the way for improved treatment options, ultimately enhancing patient quality of life.